PFGIA
CRBP icon

Patriot Financial Group Insurance Agency’s Corbus Pharmaceuticals CRBP Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-42
Closed -$10K – 1694
2020
Q2 		$10K Buy
+42
New +$8.49K ﹤0.01% 972

Other funds holding CRBP

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Patriot Financial Group Insurance Agency's CRBP Position: Q3 2020 in Review

Patriot Financial Group Insurance Agency sold out of Corbus Pharmaceuticals (CRBP) in Q3 2020, closing a stake of 42 shares — an estimated $10K sold.

Patriot Financial Group Insurance Agency first reported a position in CRBP in Q2 2020 and held it in 1 quarter. The position peaked at $10K in Q2 2020. 122 funds tracked by Wall St. Rank hold CRBP as of Q3 2020.

  • Patriot Financial Group Insurance Agency reported no remaining Corbus Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 42 Corbus Pharmaceuticals shares in Q3 2020, an estimated $10K.
  • Patriot Financial Group Insurance Agency first reported a position in Corbus Pharmaceuticals in Q2 2020 and held it in 1 quarter.
  • Patriot Financial Group Insurance Agency's Corbus Pharmaceuticals position peaked at $10K in Q2 2020.
  • 122 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2020.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2020, filed 21 Oct 2020.